Align Technology (ALGN) Expected to Release Quarterly Earnings on Wednesday

Key Points

• Align Technology is expected to report Q3 2026 results after market close on October 28. Analysts forecast earnings of $2.78 per share on $1.01 billion in revenue.
• In the prior quarter, Align earned $2.64 per share, beating estimates, while revenue rose 4.3% year over year to $1.06 billion.
• Analyst sentiment remains a “Moderate Buy,” but several firms recently lowered price targets. The stock was trading near $150.49, below its 50-day and 200-day moving averages.

Align Technology (NASDAQ:ALGN - Get Free Report) is expected to be releasing its Q3 2026 results after the market closes on Wednesday, October 28th. Analysts expect the company to post earnings of $2.78 per share and revenue of $1.01 billion for the quarter. Interested persons are encouraged to explore the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Wednesday, October 28, 2026 at 4:30 PM ET.

Align Technology (NASDAQ:ALGN - Get Free Report) last released its earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 earnings per share for the quarter, beating analysts' consensus estimates of $2.62 by $0.02. Align Technology had a net margin of 9.99% and a return on equity of 15.86%. The firm had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.05 billion. During the same period in the previous year, the company earned $2.49 earnings per share. The company's quarterly revenue was up 4.3% on a year-over-year basis. On average, analysts expect Align Technology to post $9.36 EPS for the current fiscal year and $10.40 EPS for the next fiscal year.

Align Technology Stock Up 1.0%

Align Technology stock opened at $150.49 on Wednesday. The firm has a 50 day moving average price of $153.02 and a 200-day moving average price of $166.88. Align Technology has a twelve month low of $130.23 and a twelve month high of $200.43. The company has a market capitalization of $10.78 billion, a P/E ratio of 16.50, a P/E/G ratio of 1.59 and a beta of 1.67.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Evercore cut shares of Align Technology from an "outperform" rating to an "in-line" rating and set a $155.00 price target on the stock. in a report on Monday, October 5th. Stifel Nicolaus reduced their price objective on Align Technology from $210.00 to $175.00 and set a "buy" rating for the company in a report on Friday, October 9th. Robert W. Baird reissued a "neutral" rating and issued a $162.00 target price (down from $218.00) on shares of Align Technology in a research report on Thursday, October 15th. Weiss Ratings raised Align Technology from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, October 9th. Finally, Leerink Partners lowered their target price on Align Technology from $235.00 to $215.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $194.14.

About Align Technology

Align Technology, Inc is a global medical device company focused on digital orthodontics and restorative dentistry. Founded in 1997, the company is best known for the Invisalign system, a series of clear, removable aligners designed to gradually move teeth and treat a range of orthodontic conditions.

Align's products and services also include digital scanning and dental practice solutions. Its iTero intraoral scanners create digital impressions for orthodontic and restorative procedures, while its exocad business develops computer-aided design and computer-aided manufacturing software used by dental laboratories, clinicians and other dental professionals.

The company serves orthodontists, dentists, dental laboratories and patients in numerous markets worldwide.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.